Albella B - Search Results

1

Inhibitory effects of marine-derived DNA-binding anti-tumour tetrahydroisoquinolines on the Fanconi anaemia pathway.

Martínez S, Pérez L, Galmarini CM, Aracil M, Tercero JC, Gago F, Albella B, Bueren JA. Martínez S, et al. Among authors: albella b. Br J Pharmacol. 2013 Oct;170(4):871-82. doi: 10.1111/bph.12331. Br J Pharmacol. 2013. PMID: 23937566 Free PMC article.

2

Relevance of the Fanconi anemia pathway in the response of human cells to trabectedin.

Casado JA, Río P, Marco E, García-Hernández V, Domingo A, Pérez L, Tercero JC, Vaquero JJ, Albella B, Gago F, Bueren JA. Casado JA, et al. Among authors: albella b. Mol Cancer Ther. 2008 May;7(5):1309-18. doi: 10.1158/1535-7163.MCT-07-2432. Mol Cancer Ther. 2008. PMID: 18483318

3

In vitro toxicity of three new antitumoral drugs (trabectedin, aplidin, and kahalalide F) on hematopoietic progenitors and stem cells.

Gómez SG, Bueren JA, Faircloth GT, Jimeno J, Albella B. Gómez SG, et al. Among authors: albella b. Exp Hematol. 2003 Nov;31(11):1104-11. Exp Hematol. 2003. PMID: 14585376 Free article.

4

Use of CFU-GM assay for prediction of human maximum tolerated dose of a new antitumoral drug: Yondelis (ET-743).

Gómez SG, Bueren JA, Faircloth G, Albella B. Gómez SG, et al. Among authors: albella b. Toxicol In Vitro. 2003 Oct-Dec;17(5-6):671-4. doi: 10.1016/s0887-2333(03)00139-5. Toxicol In Vitro. 2003. PMID: 14599461

5

Development of an in vitro model for the simultaneous study of the efficacy and hematotoxicity of antileukemic compounds.

Valeri A, Alonso-Ferrero ME, Cerrato L, Martínez S, Bueren JA, Albella B. Valeri A, et al. Among authors: albella b. Toxicol Lett. 2010 Dec 15;199(3):317-22. doi: 10.1016/j.toxlet.2010.09.014. Epub 2010 Sep 29. Toxicol Lett. 2010. PMID: 20883753

6

Bcr/Abl interferes with the Fanconi anemia/BRCA pathway: implications in the chromosomal instability of chronic myeloid leukemia cells.

Valeri A, Alonso-Ferrero ME, Río P, Pujol MR, Casado JA, Pérez L, Jacome A, Agirre X, Calasanz MJ, Hanenberg H, Surrallés J, Prosper F, Albella B, Bueren JA. Valeri A, et al. Among authors: albella b. PLoS One. 2010 Dec 28;5(12):e15525. doi: 10.1371/journal.pone.0015525. PLoS One. 2010. PMID: 21203397 Free PMC article.

7

In vitro sensitivity of granulo-monocytic progenitors as a new toxicological cell system and endpoint in the ACuteTox Project.

Cerrato L, Valeri A, Bueren JA, Albella B. Cerrato L, et al. Among authors: albella b. Toxicol Appl Pharmacol. 2009 Jul 15;238(2):111-9. doi: 10.1016/j.taap.2009.05.005. Epub 2009 May 12. Toxicol Appl Pharmacol. 2009. PMID: 19442680

8

In vitro toxicity of ET-743 and aplidine, two marine-derived antineoplastics, on human bone marrow haematopoietic progenitors. comparison with the clinical results.

Albella B, Faircloth G, López-Lázaro L, Guzmán C, Jimeno J, Bueren JA. Albella B, et al. Eur J Cancer. 2002 Jul;38(10):1395-404. doi: 10.1016/s0959-8049(01)00245-3. Eur J Cancer. 2002. PMID: 12091072

9

Ex vivo expansion of hematopoietic stem cells.

Albella B, Segovia JC, Guenechea G, Bueren JA. Albella B, et al. Methods Mol Biol. 2003;215:363-73. doi: 10.1385/1-59259-345-3:363. Methods Mol Biol. 2003. PMID: 12512312 No abstract available.

10

Does the granulocyte-macrophage colony-forming unit content in ex vivo-expanded grafts predict the recovery of the recipient leukocytes?

Albella B, Segovia JC, Bueren JA. Albella B, et al. Blood. 1997 Jul 1;90(1):464-70. Blood. 1997. PMID: 9207484 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters